Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 11:34:100753.
doi: 10.1016/j.lanepe.2023.100753. eCollection 2023 Nov.

Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt

Daniele De Luca  1   2 , Manuel Sanchez-Luna  3 , Karl Schettler  4 , Louis Bont  5   6 , Eugenio Baraldi  6   7
Affiliations

Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt

Daniele De Luca et al. Lancet Reg Health Eur. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

DDL received consultancy and lecture fees from Chiesi Farmaceutici, Getinge, Vyaire, Radiometer, Medtronic, Astra Zeneca, Boehringer Ingelheim, Airway Therapeutics, Natus, Masimo; he also has equity options from Ophirex ltd. All these were unrelated to the present work and to nirsevimab and the universal RSV immunisation. MSL received consultancy and lecture fees from Medtronic, Astra Zeneca, and Sanofi, all outside of the present work and unrelated to nirsevimab and the universal RSV immunisation. EB received consultancy and lecture fees and participated to advisory boards for Astra-Zeneca and Sanofi, all outside of the present work. LB is the founding chairman of the ReSViNET Foundation. He has not received any personal benefit. His institution has conversely received research grants from AbbVie, MedImmune, AstraZeneca, Sanofi, Janssen, Pfizer, MSD and MeMed Diagnostics, GSK and Novavax, Julius Clinical. His institution also received consultancy and invited lecture fees by AbbVie, MedImmune, Ablynx, Bavaria Nordic, MabXience, GSK, Novavax, Pfizer, Moderna, Astrazeneca, MSD, Sanofi and Janssen. All these were unrelated to the present work. KS has no conflict of interest to declare. This work did not receive any funding.

Figures

Fig. 1
Fig. 1
Diffusion of universal RSV immunisation in European Union countries. Data obtained by contacting directly local clinical key opinion leaders or authorities (personal communications updated at October 3, 2023).
See this image and copyright information in PMC

References

    1. Wildenbeest J.G., Billard M.-N., Zuurbier R.P., et al. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study. Lancet Respir Med. 2023;11:341–353. doi: 10.1016/S2213-2600(22)00414-3. - DOI - PMC - PubMed
    1. De Luca D., Tingay D.G., van Kaam A.H., et al. Neonatal ARDS Project Collaboration Group. Epidemiology of neonatal acute respiratory distress syndrome: prospective, multicenter, International Cohort Study. Pediatr Crit Care Med. 2022;23:524–534. doi: 10.1097/PCC.0000000000002961. - DOI - PubMed
    1. De Luca D., Piastra M., Chidini G., et al. Respiratory Section of the European Society for Pediatric Neonatal Intensive Care (ESPNIC). The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus. Intensive Care Med. 2013;39:2083–2091. doi: 10.1007/s00134-013-3110-x. - DOI - PubMed
    1. Linssen R.S., Teirlinck A.C., van Boven M., et al. Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study. J Crit Care. 2022;68:165–168. doi: 10.1016/j.jcrc.2021.07.009. - DOI - PubMed
    1. Fairbank R. RSV wave hammers hospitals–but vaccines and treatments are coming. Nature. 2022 doi: 10.1038/d41586-022-04434-5. - DOI - PubMed

LinkOut - more resources